Thailand · Delayed Price · Currency is THB Healthlead PCL Statistics
Total Valuation
Healthlead PCL has a market cap or net worth of THB 1.40 billion. The enterprise value is 1.19 billion.
| Market Cap | 1.40B |
| Enterprise Value | 1.19B |
Important Dates
The next estimated earnings date is Friday, August 7, 2026.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | Mar 11, 2026 |
Share Statistics
Healthlead PCL has 254.30 million shares outstanding. The number of shares has increased by 1.06% in one year.
| Current Share Class | 254.30M |
| Shares Outstanding | 254.30M |
| Shares Change (YoY) | +1.06% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 73.78% |
| Owned by Institutions (%) | 0.20% |
| Float | 66.67M |
Valuation Ratios
The trailing PE ratio is 18.97.
| PE Ratio | 18.97 |
| Forward PE | n/a |
| PS Ratio | 0.61 |
| PB Ratio | 1.47 |
| P/TBV Ratio | 1.51 |
| P/FCF Ratio | 9.15 |
| P/OCF Ratio | 7.72 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.85, with an EV/FCF ratio of 7.77.
| EV / Earnings | 15.65 |
| EV / Sales | 0.52 |
| EV / EBITDA | 5.85 |
| EV / EBIT | 10.75 |
| EV / FCF | 7.77 |
Financial Position
The company has a current ratio of 3.03, with a Debt / Equity ratio of 0.34.
| Current Ratio | 3.03 |
| Quick Ratio | 1.83 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | 1.57 |
| Debt / FCF | 2.10 |
| Interest Coverage | 6.39 |
Financial Efficiency
Return on equity (ROE) is 7.69% and return on invested capital (ROIC) is 8.82%.
| Return on Equity (ROE) | 7.69% |
| Return on Assets (ROA) | 4.39% |
| Return on Invested Capital (ROIC) | 8.82% |
| Return on Capital Employed (ROCE) | 8.74% |
| Weighted Average Cost of Capital (WACC) | 5.58% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.47 |
| Inventory Turnover | 4.86 |
Taxes
In the past 12 months, Healthlead PCL has paid 19.69 million in taxes.
| Income Tax | 19.69M |
| Effective Tax Rate | 20.59% |
Stock Price Statistics
The stock price has decreased by -20.71% in the last 52 weeks. The beta is 0.30, so Healthlead PCL's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | -20.71% |
| 50-Day Moving Average | 5.93 |
| 200-Day Moving Average | 6.84 |
| Relative Strength Index (RSI) | 38.05 |
| Average Volume (20 Days) | 39,202 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Healthlead PCL had revenue of THB 2.29 billion and earned 75.94 million in profits. Earnings per share was 0.29.
| Revenue | 2.29B |
| Gross Profit | 591.25M |
| Operating Income | 109.31M |
| Pretax Income | 95.64M |
| Net Income | 75.94M |
| EBITDA | 154.89M |
| EBIT | 109.31M |
| Earnings Per Share (EPS) | 0.29 |
Balance Sheet
The company has 531.27 million in cash and 320.96 million in debt, with a net cash position of 210.31 million or 0.83 per share.
| Cash & Cash Equivalents | 531.27M |
| Total Debt | 320.96M |
| Net Cash | 210.31M |
| Net Cash Per Share | 0.83 |
| Equity (Book Value) | 949.57M |
| Book Value Per Share | 3.70 |
| Working Capital | 633.75M |
Cash Flow
In the last 12 months, operating cash flow was 181.27 million and capital expenditures -28.37 million, giving a free cash flow of 152.90 million.
| Operating Cash Flow | 181.27M |
| Capital Expenditures | -28.37M |
| Depreciation & Amortization | 45.58M |
| Net Borrowing | -56.40M |
| Free Cash Flow | 152.90M |
| FCF Per Share | 0.60 |
Margins
Gross margin is 25.86%, with operating and profit margins of 4.78% and 3.32%.
| Gross Margin | 25.86% |
| Operating Margin | 4.78% |
| Pretax Margin | 4.18% |
| Profit Margin | 3.32% |
| EBITDA Margin | 6.78% |
| EBIT Margin | 4.78% |
| FCF Margin | 6.69% |
Dividends & Yields
This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 4.00%.
| Dividend Per Share | 0.22 |
| Dividend Yield | 4.00% |
| Dividend Growth (YoY) | 29.41% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 60.89% |
| Buyback Yield | -1.06% |
| Shareholder Yield | 2.87% |
| Earnings Yield | 5.43% |
| FCF Yield | 10.93% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Healthlead PCL has an Altman Z-Score of 4.22 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.22 |
| Piotroski F-Score | 6 |